Skip to main content

Table 2 Demographic information and baseline characteristics of patients in MEXCOVID study

From: Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study

 

Age (years)

Sex

Occupation

Allergic history

Smoking history (pack years)

Clinical classification

Days of admission from symptom onset (days)

Days of haMSCs-Exos nebulization from symptom onset (days)

Principal symptoms

Comorbidity

Patient 1

34

Male

Unemployed

Denied

400

Severe

15

32

Fever, shortness of breath

Hypertension

Patient 2

51

Female

Self-employed

Denied

None

Severe

15

59

Fever, sore throat, shortness of breath, cough, expectoration, malaise

None

Patient 3

43

Male

Employee

Denied

None

Severe

30

34

Fever, cough

Diabetes, Hypertension

Patient 4

60

Male

Employee

Denied

800

Severe

40

85

Fever, cough, malaise, shortness of breath

Chronic obstructive pulmonary disease, hypertension

Patient 5

57

Female

Unemployed

Denied

None

Severe

11

69

Fever, headache, diarrhea

Hyperthyroidism

Patient 6

75

Male

Unemployed

Denied

None

Severe

44

54

Fever, cough, shortness of breath, malaise

None

Patient 7

70

Female

Unemployed

Penicillin

None

Severe

38

47

Fever, cough, shortness of breath

Diabetes